Page last updated: 2024-08-17

carbostyril and Addiction, Opioid

carbostyril has been researched along with Addiction, Opioid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruce, RD; Custodio, JM; Friedland, GH; Kearney, BP; Ramanathan, S; Rhee, MS; Wei, LX; Winkle, P1
Bruce, RD; Custodio, JM; Friedland, GH; Kearney, BP; Ramanathan, S; Rhee, MS; Wei, X; Winkle, P1
Bruno, A; Muscatello, MR; Pandolfo, G; Romeo, VM; Scimeca, G; Zoccali, RA1
Aguiar, DC; Almeida-Santos, AF; Duarte, ID; Ferreira, RC; Gobira, PH; Moreira, FA; Romero, TR; Souza, DP1
Guo, H; Lai, J; Wang, Y; Yan, P; Yin, F; Zhang, J1

Trials

1 trial(s) available for carbostyril and Addiction, Opioid

ArticleYear
Aripiprazole plus topiramate in opioid-dependent patients with schizoaffective disorder: an 8-week, open-label, uncontrolled, preliminary study.
    Substance abuse, 2014, Volume: 35, Issue:2

    Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Diagnosis, Dual (Psychiatry); Drug Administration Schedule; Drug Therapy, Combination; Female; Fructose; Humans; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Topiramate; Treatment Outcome; Young Adult

2014

Other Studies

4 other study(ies) available for carbostyril and Addiction, Opioid

ArticleYear
The pharmacokinetic and pharmacodynamic interactions between buprenorphine/naloxone and elvitegravir/cobicistat in subjects receiving chronic buprenorphine/naloxone treatment.
    Journal of acquired immune deficiency syndromes (1999), 2013, Aug-01, Volume: 63, Issue:4

    Topics: Adult; Anti-Retroviral Agents; Area Under Curve; Buprenorphine; Carbamates; Cobicistat; Drug Interactions; Female; HIV Infections; HIV Seronegativity; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Quinolones; Thiazoles

2013
Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenance.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Adult; Anti-HIV Agents; Area Under Curve; Carbamates; Cobicistat; Drug Interactions; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Quinolones; Thiazoles

2013
The antipsychotic aripiprazole selectively prevents the stimulant and rewarding effects of morphine in mice.
    European journal of pharmacology, 2014, Nov-05, Volume: 742

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Central Nervous System Stimulants; Conditioning, Psychological; Disease Models, Animal; Male; Mice; Morphine; Motor Activity; Nociception; Opioid-Related Disorders; Piperazines; Quinolones; Reward

2014
The Role of Dopamine D1 and D3 Receptors in N-Methyl-D-Aspartate (NMDA)/GlycineB Site-Regulated Complex Cognitive Behaviors following Repeated Morphine Administration.
    The international journal of neuropsychopharmacology, 2017, 07-01, Volume: 20, Issue:7

    Topics: Analgesics, Opioid; Analysis of Variance; Animals; Choice Behavior; Cognition Disorders; Cyclopentanes; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Impulsive Behavior; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Opioid-Related Disorders; Quinolones; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D3; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate

2017